Zobrazeno 1 - 10
of 45
pro vyhledávání: '"MESH: Drug Discovery"'
Autor:
Paul Ogadinma, Yann Ayotte, Laurent Chatel-Chaix, François Bilodeau, Marthe Lebughe, Mena Cimino, Giulia Manina, Aïssatou Aïcha Sow, Frédéric J. Veyrier, Albert Descoteaux, Eve Bernet, Dominic Gagnon, Sarah-Lisa Ouali, Maxime Mistretta, Dave Richard, Steven R. LaPlante
Publikováno v:
ACS Chemical Biology
ACS Chemical Biology, 2021, 16 (11), pp.2158-2163. ⟨10.1021/acschembio.1c00657⟩
ACS Chemical Biology, 2021, 16 (11), pp.2158-2163. ⟨10.1021/acschembio.1c00657⟩
International audience; Fragment-based lead discovery has emerged over the last decades as one of the most powerful techniques for identifying starting chemical matter to target specific proteins or nucleic acids in vitro. However, the use of such lo
Autor:
Gütschow, Michael, Eynde, Jean Jacques Vanden, Jampilek, Josef, Kang, CongBao, Mangoni, Arduino, Fossa, Paola, Karaman, Rafik, Trabocchi, Andrea, Scott, Peter, Reynisson, Jóhannes, Rapposelli, Simona, Galdiero, Stefania, Winum, Jean-Yves, Brullo, Chiara, Prokai-Tatrai, Katalin, Sharma, Arun, Schapira, Matthieu, Azuma, Yasu-Taka, Cerchia, Laura, Spetea, Mariana, Torri, Giangiacomo, Collina, Simona, Geronikaki, Athina, García-Sosa, Alfonso, Vasconcelos, M Helena, Sousa, Maria Emília, Kosalec, Ivan, Tuccinardi, Tiziano, Duarte, Iola, Salvador, Jorge, Bertinaria, Massimo, Pellecchia, Maurizio, Amato, Jussara, Rastelli, Giulio, Gomes, Paula, Guedes, Rita, Sabatier, Jean-Marc, Estévez-Braun, Ana, Pagano, Bruno, Mangani, Stefano, Ragno, Rino, Kokotos, George, Brindisi, Margherita, González, Florenci, Borges, Fernanda, Miloso, Mariarosaria, Rautio, Jarkko, Muñoz-Torrero, Diego, Vanden Eynde, Jean Jacques, Vasconcelos, M. Helena
Publikováno v:
Molecules
Molecules, MDPI, 2020, 25 (13), pp.2968. ⟨10.3390/molecules25132968⟩
Molecules, Vol 25, Iss 2968, p 2968 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
Molecules (Basel, Online) 25 (2020). doi:10.3390/molecules25132968
info:cnr-pdr/source/autori:Gutschow M.; Eynde J.J.V.; Jampilek J.; Kang C.; Mangoni A.A.; Fossa P.; Karaman R.; Trabocchi A.; Scott P.J.H.; Reynisson J.; Rapposelli S.; Galdier S.; Winum J.-Y.; Brullo C.; Prokai-Tatrai K.; Sharma A.K.; Schapira M.; Azuma Y.-T.; Cerchia L.; Spete M.; Torri G.; Collina S.; Geronikaki A.; Garcia-Sosa A.T.; Helena Vasconcelos M.; Sousa M.E.; Kosalec I.; Tuccinardi T.; Duarte I.F.; Salvador J.A.R.; Bertinaria M.; Pellecchia M.; Amato J.; Rastelli G.; Gomes P.A.C.; Guedes R.C.; Sabatier J.-M.; Estevez-Braun A.; Pagano B.; Mangani S.; Ragno R.; Kokotos G.; Brindisi M.; Gonzalez F.V.; Borges F.; Miloso M.; Rautio J.; Munoz-Torrero D./titolo:Breakthroughs in medicinal chemistry: New targets and mechanisms, new drugs, new hopes-7/doi:10.3390%2Fmolecules25132968/rivista:Molecules (Basel, Online)/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume:25
Molecules, 2020, 25 (13), pp.2968. ⟨10.3390/molecules25132968⟩
Repositori Universitat Jaume I
Universitat Jaume I
Molecules, MDPI, 2020, 25 (13), pp.2968. ⟨10.3390/molecules25132968⟩
Molecules, Vol 25, Iss 2968, p 2968 (2020)
Dipòsit Digital de la UB
Universidad de Barcelona
Molecules (Basel, Online) 25 (2020). doi:10.3390/molecules25132968
info:cnr-pdr/source/autori:Gutschow M.; Eynde J.J.V.; Jampilek J.; Kang C.; Mangoni A.A.; Fossa P.; Karaman R.; Trabocchi A.; Scott P.J.H.; Reynisson J.; Rapposelli S.; Galdier S.; Winum J.-Y.; Brullo C.; Prokai-Tatrai K.; Sharma A.K.; Schapira M.; Azuma Y.-T.; Cerchia L.; Spete M.; Torri G.; Collina S.; Geronikaki A.; Garcia-Sosa A.T.; Helena Vasconcelos M.; Sousa M.E.; Kosalec I.; Tuccinardi T.; Duarte I.F.; Salvador J.A.R.; Bertinaria M.; Pellecchia M.; Amato J.; Rastelli G.; Gomes P.A.C.; Guedes R.C.; Sabatier J.-M.; Estevez-Braun A.; Pagano B.; Mangani S.; Ragno R.; Kokotos G.; Brindisi M.; Gonzalez F.V.; Borges F.; Miloso M.; Rautio J.; Munoz-Torrero D./titolo:Breakthroughs in medicinal chemistry: New targets and mechanisms, new drugs, new hopes-7/doi:10.3390%2Fmolecules25132968/rivista:Molecules (Basel, Online)/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume:25
Molecules, 2020, 25 (13), pp.2968. ⟨10.3390/molecules25132968⟩
Repositori Universitat Jaume I
Universitat Jaume I
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes is a series of editorials which is published on a biannual basis by the Editorial Board of the Medicinal Chemistry section of the journal Molecules. In these edito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e417a8ae7bdaece7cdb0a324d6fe2a63
http://hdl.handle.net/11573/1511684
http://hdl.handle.net/11573/1511684
Autor:
Nicolas Wolff, Angelita Rebollo, Chang-Zhi Dong, Heriberto Bruzzoni-Giovanelli, Valérie Alezra, Pierre Tufféry
Publikováno v:
Drug Discovery Today Biosilico
Drug Discovery Today Biosilico, Elsevier, 2018, 23 (2), pp.272-285. ⟨10.1016/j.drudis.2017.10.016⟩
Drug Discovery Today Biosilico, 2018, 23 (2), pp.272-285. ⟨10.1016/j.drudis.2017.10.016⟩
Drug Discovery Today Biosilico, Elsevier, 2018, 23 (2), pp.272-285. ⟨10.1016/j.drudis.2017.10.016⟩
Drug Discovery Today Biosilico, 2018, 23 (2), pp.272-285. ⟨10.1016/j.drudis.2017.10.016⟩
International audience; Protein-protein interactions (PPIs) are well recognized as promising therapeutic targets. Consequently, interfering peptides (IPs) - natural or synthetic peptides capable of interfering with PPIs - are receiving increasing att
Publikováno v:
Natural Product Reports
Natural Product Reports, Royal Society of Chemistry, 2018, 35 (2), pp.147-173. ⟨10.1039/c7np00032d⟩
Natural Product Reports, 2018, 35 (2), pp.147-173. ⟨10.1039/c7np00032d⟩
Natural Product Reports, Royal Society of Chemistry, 2018, 35 (2), pp.147-173. ⟨10.1039/c7np00032d⟩
Natural Product Reports, 2018, 35 (2), pp.147-173. ⟨10.1039/c7np00032d⟩
International audience; Fungal secondary metabolites are defined by bioactive properties that ensure adaptation of the fungus to its environment. Although some of these natural products are promising sources of new lead compounds especially for the p
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Clinical Epigenetics
Clinical Epigenetics, BioMed Central, 2019, 11 (1), pp.174. ⟨10.1186/s13148-019-0776-0⟩
Clinical Epigenetics, 2019, 11 (1), pp.174. ⟨10.1186/s13148-019-0776-0⟩
Universidad de Barcelona
Clinical Epigenetics
Clinical Epigenetics, BioMed Central, 2019, 11 (1), pp.174. ⟨10.1186/s13148-019-0776-0⟩
Clinical Epigenetics, 2019, 11 (1), pp.174. ⟨10.1186/s13148-019-0776-0⟩
The flexibility of the epigenome has generated an enticing argument to explore its reversion through pharmacological treatments as a strategy to ameliorate disease phenotypes. All three families of epigenetic proteins—readers, writers, and erasers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da45d7a237afb15483829aeb3ef082b
http://hdl.handle.net/2445/168017
http://hdl.handle.net/2445/168017
Autor:
Martine Pugnière, Alain Chavanieu
Publikováno v:
Expert Opinion on Drug Discovery
Expert Opinion on Drug Discovery, Informa Healthcare, 2016, 11 (5), pp.489-499. ⟨10.1517/17460441.2016.1160888⟩
Expert Opinion on Drug Discovery, Informa Healthcare, 2016, 11 (5), pp.489-499. ⟨10.1517/17460441.2016.1160888⟩
International audience; INTRODUCTION:Fragment-based approaches have played an increasing role alongside high-throughput screening in drug discovery for 15 years. The label-free biosensor technology based on surface plasmon resonance (SPR) is now sens
Publikováno v:
Molecular Informatics
Molecular Informatics, Wiley-VCH, 2018, 37 (9-10), pp.1800059. ⟨10.1002/minf.201800059⟩
Molecular Informatics, 2018, 37 (9-10), pp.1800059. ⟨10.1002/minf.201800059⟩
Molecular Informatics, Wiley-VCH, 2018, 37 (9-10), pp.1800059. ⟨10.1002/minf.201800059⟩
Molecular Informatics, 2018, 37 (9-10), pp.1800059. ⟨10.1002/minf.201800059⟩
International audience; For several decades, hit identification for drug discovery has been facilitated by developments in both fragment-based and high-throughput screening technologies. However, a major bottleneck in drug discovery projects continue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bc4f6ba0760ac897f7ee7430cddd8da
https://hal.archives-ouvertes.fr/hal-02145522
https://hal.archives-ouvertes.fr/hal-02145522
Autor:
Bruce S. Seal, Djamel Drider, Brian B. Oakley, Harald Brüssow, David Bikard, Joseph O. Rich, Stefan Miller, Estelle Devillard, Jason Kwan, Gérard Bertin, Stuart Reeves, Steven M. Swift, Margot Raicek, Cyril G. Gay
Publikováno v:
Veterinary Research
Veterinary Research, BioMed Central, 2018, 49 (1), pp.66. ⟨10.1186/s13567-018-0563-5⟩
Veterinary Research, 2018, 49 (1), pp.66. ⟨10.1186/s13567-018-0563-5⟩
Veterinary Research, Vol 49, Iss 1, Pp 1-12 (2018)
Veterinary Research, BioMed Central, 2018, 49 (1), pp.66. ⟨10.1186/s13567-018-0563-5⟩
Veterinary Research, 2018, 49 (1), pp.66. ⟨10.1186/s13567-018-0563-5⟩
Veterinary Research, Vol 49, Iss 1, Pp 1-12 (2018)
International audience; Due to the continuing global concerns involving antibiotic resistance, there is a need for scientific forums to assess advancements in the development of antimicrobials and their alternatives that might reduce development and
Autor:
Francesco Iorio, Elisabeth Chen, Thomas Cokelaer, Howard Lightfoot, Mathew J. Garnett, Julio Saez-Rodriguez, Michael P. Menden
Publikováno v:
Bioinformatics
Bioinformatics, 2018, 34 (7), pp.1226-1228. ⟨10.1093/bioinformatics/btx744⟩
Bioinformatics, Oxford University Press (OUP), 2018, 34 (7), pp.1226-1228. ⟨10.1093/bioinformatics/btx744⟩
Bioinformatics 34(7), 1226-1228 (2018). doi:10.1093/bioinformatics/btx744
Bioinformatics, 2018, 34 (7), pp.1226-1228. ⟨10.1093/bioinformatics/btx744⟩
Bioinformatics, Oxford University Press (OUP), 2018, 34 (7), pp.1226-1228. ⟨10.1093/bioinformatics/btx744⟩
Bioinformatics 34(7), 1226-1228 (2018). doi:10.1093/bioinformatics/btx744
Motivation Large pharmacogenomic screenings integrate heterogeneous cancer genomic datasets as well as anti-cancer drug responses on thousand human cancer cell lines. Mining this data to identify new therapies for cancer sub-populations would benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4a0cbedb6f2ff9b8636fdb0daab5134
Publikováno v:
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Public Library of Science, 2017, 11 (6), pp.e0005480. ⟨10.1371/journal.pntd.0005480⟩
PLOS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, 2017, 11 (6), pp.e0005480. ⟨10.1371/journal.pntd.0005480⟩
PLoS Neglected Tropical Diseases, Vol 11, Iss 6, p e0005480 (2017)
PLoS Neglected Tropical Diseases, Public Library of Science, 2017, 11 (6), pp.e0005480. ⟨10.1371/journal.pntd.0005480⟩
PLOS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, 2017, 11 (6), pp.e0005480. ⟨10.1371/journal.pntd.0005480⟩
PLoS Neglected Tropical Diseases, Vol 11, Iss 6, p e0005480 (2017)
International audience; The state of antileishmanial chemotherapy is strongly compromised by the emergence of drug-resistant Leishmania. The evolution of drug-resistant phenotypes has been linked to the parasites’ intrinsic genome instability, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::547b6df90b34fd156ee577c323382b33
https://hal-pasteur.archives-ouvertes.fr/pasteur-01570238/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-01570238/document